Figs, Inc. FIGS
We take great care to ensure that the data presented and summarized in this overview for FIGS, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FIGS
View all-
Bamco Inc New York, NY30.8MShares$170 Million0.51% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$70.4 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN12.2MShares$67 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$58.7 Million0.04% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$57.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.35MShares$23.9 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.97MShares$16.3 Million0.0% of portfolio
-
State Street Corp Boston, MA2.88MShares$15.9 Million0.0% of portfolio
-
Applied Fundamental Research, LLC Cambridge, MA2.49MShares$13.7 Million12.88% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL2.4MShares$13.2 Million0.1% of portfolio
Latest Institutional Activity in FIGS
Top Purchases
Top Sells
About FIGS
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, and jackets. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.
Insider Transactions at FIGS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 11
2025
|
Thomas Tull |
SELL
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
19,039,999
-74.04%
|
$114,239,994
$6.25 P/Share
|
|
Jan 06
2025
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
26,855
-7.05%
|
$134,275
$5.96 P/Share
|
|
Jan 02
2025
|
Melanie Anya Whelan Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,815
+50.0%
|
-
|
|
Dec 17
2024
|
Alan G Lafley Director |
SELL
Bona fide gift
|
Indirect |
768,384
-84.48%
|
-
|
|
Dec 04
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
3,076
-0.8%
|
$15,380
$5.19 P/Share
|
|
Nov 06
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
38,575
-9.13%
|
$231,450
$6.32 P/Share
|
|
Sep 05
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
2,983
-0.7%
|
$17,898
$6.19 P/Share
|
|
Aug 12
2024
|
Sarah Oughtred Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
656,815
+50.0%
|
-
|
|
Aug 07
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
40,149
-8.62%
|
$200,745
$5.7 P/Share
|
|
Aug 07
2024
|
Kevin Fosty Former Interim CFO |
SELL
Open market or private sale
|
Direct |
454
-0.69%
|
$2,270
$5.7 P/Share
|
|
Jul 03
2024
|
Kevin Fosty Former Interim CFO |
SELL
Open market or private sale
|
Direct |
1,005
-1.5%
|
$5,025
$5.53 P/Share
|
|
Jun 13
2024
|
Alan G Lafley Director |
SELL
Bona fide gift
|
Direct |
18,227
-28.0%
|
-
|
|
Jun 05
2024
|
John Martin Willhite Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,143
+0.87%
|
-
|
|
Jun 05
2024
|
Alan G Lafley Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,143
+30.18%
|
-
|
|
Jun 05
2024
|
Jeffrey A Wilke Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,143
+13.35%
|
-
|
|
Jun 05
2024
|
Mario Jesus Marte Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,143
+40.6%
|
-
|
|
Jun 05
2024
|
Kenneth Jian Hong Lin Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,143
+19.41%
|
-
|
|
Jun 05
2024
|
Sheila Antrum Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,143
+28.45%
|
-
|
|
Jun 04
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
3,011
-0.64%
|
$15,055
$5.19 P/Share
|
|
Jun 04
2024
|
Kevin Fosty Former Interim CFO |
SELL
Open market or private sale
|
Direct |
19
-0.03%
|
$95
$5.19 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.51M shares |
|---|
| Open market or private sale | 162K shares |
|---|---|
| Bona fide gift | 787K shares |
| Exercise of in-the-money or at-the-money derivatives securities | 19M shares |